Advanced search
1 file | 504.88 KB Add to list

In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model

(2005) CLINICAL CANCER RESEARCH. 11(20). p.7288-7296
Author
Organization

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 504.88 KB

Citation

Please use this url to cite or link to this publication:

MLA
Burvenich, Ingrid, Steve Schoonooghe, Bart Cornelissen, et al. “In Vitro and in Vivo Targeting Properties of Iodine-123- or Iodine-131-labeled Monoclonal Antibody 14C5 in a Non-small Cell Lung Cancer and Colon Carcinoma Model.” CLINICAL CANCER RESEARCH 11.20 (2005): 7288–7296. Print.
APA
Burvenich, Ingrid, Schoonooghe, S., Cornelissen, B., BLANCKAERT, P., Coene, E., Cuvelier, C., Mertens, N., et al. (2005). In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model. CLINICAL CANCER RESEARCH, 11(20), 7288–7296.
Chicago author-date
Burvenich, Ingrid, Steve Schoonooghe, Bart Cornelissen, PETER BLANCKAERT, Elisabeth Coene, Claude Cuvelier, Nico Mertens, and Guido Slegers. 2005. “In Vitro and in Vivo Targeting Properties of Iodine-123- or Iodine-131-labeled Monoclonal Antibody 14C5 in a Non-small Cell Lung Cancer and Colon Carcinoma Model.” Clinical Cancer Research 11 (20): 7288–7296.
Chicago author-date (all authors)
Burvenich, Ingrid, Steve Schoonooghe, Bart Cornelissen, PETER BLANCKAERT, Elisabeth Coene, Claude Cuvelier, Nico Mertens, and Guido Slegers. 2005. “In Vitro and in Vivo Targeting Properties of Iodine-123- or Iodine-131-labeled Monoclonal Antibody 14C5 in a Non-small Cell Lung Cancer and Colon Carcinoma Model.” Clinical Cancer Research 11 (20): 7288–7296.
Vancouver
1.
Burvenich I, Schoonooghe S, Cornelissen B, BLANCKAERT P, Coene E, Cuvelier C, et al. In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model. CLINICAL CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2005;11(20):7288–96.
IEEE
[1]
I. Burvenich et al., “In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model,” CLINICAL CANCER RESEARCH, vol. 11, no. 20, pp. 7288–7296, 2005.
@article{364046,
  author       = {Burvenich, Ingrid and Schoonooghe, Steve and Cornelissen, Bart and BLANCKAERT, PETER and Coene, Elisabeth and Cuvelier, Claude and Mertens, Nico and Slegers, Guido},
  issn         = {1078-0432},
  journal      = {CLINICAL CANCER RESEARCH},
  language     = {eng},
  number       = {20},
  pages        = {7288--7296},
  publisher    = {AMER ASSOC CANCER RESEARCH},
  title        = {In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model},
  url          = {http://dx.doi.org/10.1158/1078-0432.CCR-04-2503},
  volume       = {11},
  year         = {2005},
}

Altmetric
View in Altmetric
Web of Science
Times cited: